Aplastic anemia is a rare and potentially life-threatening condition in which the bone marrow fails to produce enough new blood cells, resulting in low numbers of red blood cells, white blood cells, and platelets, a state known as pancytopenia. The deficiency causes symptoms such as fatigue and shortness of breath f…
Aplastic anemia is a rare and potentially life-threatening condition in which the bone marrow fails to produce enough new blood cells, resulting in low numbers of red blood cells, white blood cells, and platelets, a state known as pancytopenia. The deficiency causes symptoms such as fatigue and shortness of breath from anemia, increased susceptibility to infection from too few white cells, and easy bruising or bleeding from too few platelets. Aplastic anemia can be acquired, often through an autoimmune process in which the immune system attacks the blood-forming stem cells, and may be triggered by exposure to certain drugs, toxins, radiation, or viral infections, while some forms are inherited. Treatment depends on severity and cause and may include immunosuppressive therapy, supportive transfusions, and, in suitable patients, bone marrow or stem cell transplantation. As a journal focused on Bone Marrow Biology, this page situates aplastic anemia within the broader study of hematopoiesis and bone marrow function. The article record currently associated here does not include studies specifically examining aplastic anemia, so no individual papers are cited; the page instead provides an encyclopedic overview of the condition, its causes, and its consequences for blood cell production, consistent with the journal's focus on the biology of the bone marrow.
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 12 articles above have been cited 39 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Aplastic Anemia, linking to each citing work.